Trial intelligence / Profile preview

Comparison of the Effect of Aprepitant with Ondansetron on Postoperative Nausea and Vomiting

IRCT20211205053279N3Phase 2Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in postoperative nausea and vomiting (PONV) comparing Aprepitant arm with Ondansetron arm (2 arms). Started Dec 2022; status: completed.

02

Drugs

aprepitantondansetron
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on IRCT20211205053279N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211205053279N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call